Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Potential Patchwork Of Local Drug Take-Back Programs Poses Problem For OTC Firms

This article was originally published in The Tan Sheet

Executive Summary

CHPA backs litigation challenging drug take-back requirements to help stave off a patchwork of similar programs. Consumer education requires “a long-term commitment and won't be cheap,” but the OTC industry “can push back against more onerous mandates, says CHPA chief Scott Melville.

You may also be interested in...



CHPA Optimistic Voluntary Drug Takeback Efforts Will Stall Spread Of Mandates

OTC industry trade groups will more aggressively push for an education program to encourage proper disposal of Rx and OTC drugs as states consider mandating industry-funded takeback programs and a patchwork of local ordinances expands.

CHPA Optimistic Voluntary Drug Takeback Efforts Will Stall Spread Of Mandates

OTC industry trade groups will more aggressively push for an education program to encourage proper disposal of Rx and OTC drugs as states consider mandating industry-funded takeback programs and a patchwork of local ordinances expands.

State Officials Urging Rx Pseudoephedrine Face Strong Lobby

Officials from Mississippi, Missouri, Oregon and South Carolina and the National Narcotics Officers Associations Coalition testifying before a House subcommittee call for moving all PSE products to prescription status.

Topics

UsernamePublicRestriction

Register

PS107563

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel